What is Froin syndrome, its characteristic CSF findings, and the recommended diagnostic and therapeutic approach?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Froin Syndrome

Froin syndrome is a rare CSF disorder characterized by the pathognomonic triad of xanthochromia, markedly elevated protein levels (often >500 mg/dL), and hypercoagulated CSF, resulting from spinal canal obstruction that blocks CSF circulation below the level of the blockage 1.

Characteristic CSF Findings

The defining features include:

  • Xanthochromia (yellow discoloration of CSF)
  • Severe proteinorachia - typically >500 mg/dL, though levels can reach extraordinary heights (up to 38 g/L reported) 2
  • Hypercoagulation - CSF may clot spontaneously or show marked coagulability
  • Normal or minimally elevated cell count - maintaining albuminocytologic dissociation 3

The CSF must be obtained via lumbar puncture below the level of a partial or complete spinal block 1. A unique case demonstrated this by showing normal CSF from a ventriculoperitoneal shunt (protein 70 mg/dL) while lumbar CSF showed severe proteinorachia (938 mg/dL) in the same patient 3.

Underlying Etiologies

Based on comprehensive literature review, the causes break down as 1:

  • Neoplastic processes (33%) - including multiple myeloma with leptomeningeal involvement 4
  • Non-malignant mechanical obstruction (27%) - spinal stenosis, spinal cord injury 3, 2
  • Infections (27%) - spinal abscesses 1
  • Non-infectious inflammatory processes (6%)
  • Vascular causes (6%)

Clinical Presentation

The most common symptoms reflect the underlying obstructive pathology rather than the CSF abnormalities themselves 1:

  • Paraplegia/paraparesis (64%)
  • Back pain (38%)
  • Altered mental status/confusion (23%)
  • Sciatica (17%)
  • Headaches (17%)
  • Leg sensory deficits (17%)
  • Urinary retention (14%)

Diagnostic Approach

When Froin syndrome is suspected, immediately obtain spine MRI with contrast to identify the level and cause of spinal canal obstruction 1, 3. The diagnostic workup should proceed as follows:

  1. Lumbar puncture below the suspected obstruction level - document the characteristic triad
  2. Complete spine MRI with contrast - identify mass lesions, stenosis, inflammatory processes, or structural abnormalities causing CSF flow obstruction
  3. If ventriculoperitoneal shunt present - parallel CSF sampling from shunt and lumbar space can definitively prove the diagnosis by showing normal CSF above and abnormal CSF below the obstruction 3
  4. Rule out alternative diagnoses - particularly Guillain-Barré syndrome when albuminocytologic dissociation is present, though GBS typically shows protein <500 mg/dL 5

Critical Pitfall

Do not mistake Froin syndrome for Guillain-Barré syndrome - both show albuminocytologic dissociation, but Froin syndrome demonstrates much higher protein levels (typically >500 mg/dL vs. <500 mg/dL in GBS), xanthochromia, and hypercoagulation 1, 6. The presence of structural spinal pathology on imaging distinguishes Froin syndrome.

Therapeutic Approach

Treatment must target the underlying cause of spinal canal obstruction, as the CSF abnormalities are secondary to blocked CSF circulation 1, 3:

  • Neoplastic causes - surgical decompression, radiation, or chemotherapy depending on tumor type
  • Infectious causes - surgical drainage of abscesses plus appropriate antimicrobial therapy 1
  • Mechanical obstruction - surgical decompression for stenosis or structural lesions 3
  • Inflammatory processes - immunosuppressive therapy as appropriate

Practical Consideration

Froin syndrome can interfere with intrathecal drug delivery systems - the hypercoagulated, high-protein CSF may obstruct intrathecal baclofen pumps or other delivery catheters 2. Monitor these systems closely and consider alternative routes if obstruction occurs.

Prognosis

The prognosis is poor, directly related to the underlying etiology rather than the CSF findings themselves 1:

  • Only 22% achieve full recovery after treatment
  • 22% mortality rate from the underlying cause
  • 14% retain permanent neurological sequelae
  • 42% have intermediate outcomes

Early identification of the obstructive cause and prompt definitive treatment offer the best chance for neurological recovery 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.